In brain mapping experiments, MIF‑1 increased c-Fos immunoreactivity after 4 hours in regions associated with mood, anxiety, depression, and memory.
In plain wordsIn animals, MIF‑1 increased a marker of brain cell activation after treatment.
- Peptide
- MIF-1 (Pro-Leu-Gly-NH2)
- Outcome
- IncreaseBrain c-Fos immunoreactivity
- Study
n: not reported in source
brain c-Fos mapping- Outcome group
- Receptor activity and mechanism · Nervous system and cognition
- Studied dose
- Dose not stated · 4 hoursAs given in this study.
Source sentences
The immunoreactivity of c-Fos was increased 4 hours after MIF-1 treatment in brain regions critically involved in the regulation of mood, anxiety, depression, and memory.